Bladder Cancer

Show only recruiting trials?

Roche.png

BL.13

Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer

Status

Recruiting

JCP

BL13

NCT

NCT03768570

Roche.png

CheckMate 7G8

A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (CheckMate 7G8)

Status

Recruiting

JCP

JCP074

NCT

NCT04149574

Roche.png

SGN22E (EV-302)

Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer (EV-302)

Status

Recruiting

JCP

JCP082

NCT

NCT04223856

Roche.png

B8011006

Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST)

Status

Opening Soon

JCP

JCP076

NCT

NCT04165317

Roche.png

7465-CL-0301

A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)

Status

Closed to Accrual

JCP

JCP043

NCT

NCT03474107

Filter Clinical Trials by:

arrow&v
arrow&v
arrow&v
arrow&v

Biomarkers:

No trials match your search criteria